The Mycobax market is witnessing steady growth over the forecast period, supported by increasing investment in novel immunotherapies, growing demand for alternatives to long-term antibiotics.
Read More
The Myalept market is witnessing steady growth over the forecast period, supported by increasing investments in rare disease research, rising demand for personalized metabolic therapies.
Read More
The Mvabea market is witnessing steady growth over the forecast period, supported by increasing focus on pandemic preparedness, rising funding for emerging infectious disease vaccines.
Read More
The Mumps Vaccine (MumpsVax) market is witnessing steady growth over the forecast period, supported by need to prevent re-emerging outbreaks, strengthening of school immunization policies.
Read More
The M-M-R II market is witnessing steady growth over the forecast period, supported by increasing focus on outbreak prevention, rising investments in vaccine manufacturing capacity.
Read More
The Procrit market is witnessing steady growth over the forecast period, supported by increasing focus on personalized anemia management, rising adoption of biosimilar alternatives.
Read More
The Privigen market is witnessing steady growth over the forecast period, supported by increasing demand for long-term immunotherapy treatments, expansion of homecare infusion services.
Read More
The Priorix market is witnessing steady growth over the forecast period, supported by increasing focus on disease eradication goals, rising investments in vaccine supply resilience.
Read More
The Prevnar market is witnessing steady growth over the forecast period, supported by expansion of higher-valency pneumococcal vaccines, rising focus on adult immunization schedules.
Read More
The Pre-Pen (Benzylpenicilloyl Polylysine) market is witnessing steady growth over the forecast period, supported by increasing demand for accurate antibiotic allergy diagnostics
Read More